首页 | 本学科首页   官方微博 | 高级检索  
     

老年急性髓细胞性白血病化疗方案及其疗效分析
引用本文:周明,肖佩玲,刘庭桢. 老年急性髓细胞性白血病化疗方案及其疗效分析[J]. 医学临床研究, 2006, 23(4): 560-561
作者姓名:周明  肖佩玲  刘庭桢
作者单位:湖南省人民医院血液科,湖南,长沙,410002
摘    要:【目的】探讨老年急性髓细胞性白血病的有效治疗方案。【方法】个体化中、小剂量联合化疗方案治疗老年急性髓细胞性白血病34例,总结其有效率及生存时间,并与国外相关资料进行比较。【结果】本院个体化中、小剂量联合化疗方案的有效率为70.4%,低于国外报道的79.0%,而平均生存期为228d,高于国外报道的180d。【结论】老年急性髓细胞性白血病的治疗需比较具体的个体化综合治疗方案。

关 键 词:白血病  粒细胞  急性/药物疗法
文章编号:1671-7171(2006)04-0560-02
收稿时间:2006-02-15
修稿时间:2006-02-15

Clinical Observation of 34 Acute Myeloid Leukemia in the Elderly
ZHOU Ming,XIAO Pei-ling,LIU Ting-zhen. Clinical Observation of 34 Acute Myeloid Leukemia in the Elderly[J]. Journal of Clinical Research, 2006, 23(4): 560-561
Authors:ZHOU Ming  XIAO Pei-ling  LIU Ting-zhen
Affiliation:Department of Hematology Hunan Provincial Hospital,ChangSha, Hunan 410002 ,China
Abstract:[Objective]To explore of the efficient treating method for acute myeloid leukemia in the elderly. [Methods]Middle doses combined with low doses chemotherapy were individualizedly used to treat acute myeloid leukemia in the 34 elderly cases. Efficiency and time of survival were compared with foreign reports. [Results]The efficient rate of middle dose combined with low dose chemotherapy was 70. 4%,lower than foreign reports,the average survival time was 228 days, higher than foreign reports. [Conclusion]The combined and individualized chemotherapy for the acute myeloid leukemia in the elderly could be an ideal choice.
Keywords:leukemia  myelocytic  acute/DT
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号